Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.5600
+0.0038 (0.68%)
Apr 28, 2025, 4:00 PM EDT - Market closed

Oncolytics Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
48711009776103
Upgrade
Market Cap Growth
-28.89%-28.89%3.47%27.24%-25.88%-17.85%
Upgrade
Enterprise Value
375870733982
Upgrade
PB Ratio
11.5817.134.804.952.675.29
Upgrade
P/TBV Ratio
11.5817.134.804.952.675.29
Upgrade
Debt / Equity Ratio
0.180.180.020.010.020.02
Upgrade
Quick Ratio
2.392.398.248.1515.3711.56
Upgrade
Current Ratio
2.822.829.019.0516.6912.45
Upgrade
Return on Equity (ROE)
-189.05%-189.05%-102.66%-79.34%-86.45%-182.63%
Upgrade
Return on Assets (ROA)
-74.11%-74.11%-55.46%-40.44%-40.88%-58.93%
Upgrade
Return on Capital (ROIC)
-124.82%-124.82%-76.99%-52.89%-52.97%-124.54%
Upgrade
Earnings Yield
-45.76%-30.93%-20.98%-18.95%-27.32%-17.20%
Upgrade
FCF Yield
-40.84%-26.54%-21.51%-17.86%-23.59%-16.89%
Upgrade
Buyback Yield / Dilution
-13.10%-13.10%-16.53%-8.44%-32.66%-82.22%
Upgrade
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q